Literature DB >> 6727122

Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis.

G A Kaysen, P Y Schoenfeld.   

Abstract

Albumin and protein removal rates were studied in 18 patients undergoing continuous ambulatory peritoneal dialysis (CAPD). In nine patients simultaneous studies of albumin distribution and turnover were performed. Total albumin loss was 4.23 +/- 1.42 g/1.73 m2/24 hr; total protein removed was 8.79 +/- 4.21 g/1.73 m2/24 hr. Although these values were well within the range for severe nephrosis, serum albumin concentration remained nearly normal, 3.7 +/- 0.5 g/dl. Plasma albumin mass, 120.0 +/- 25.2 g/1.73 m2, and total albumin mass, 249 +/- 29.1 g/1.73 m2, did not differ from those of the control group. Compared with the control group, patients had reduced albumin catabolism, 9.76 +/- 1.74 g/1.73 m2/24 hr versus 13.8 +/- 0.77 g/1.73 m2/24 hr (P less than 0.001). Within the patient group albumin synthesis increased with increased albumin loss. Serum albumin concentration correlated negatively with albumin losses (P less than 0.001). The CAPD patients maintained albumin homeostasis through decreased albumin catabolism and increased synthesis. All major albumin pools were maintained despite massive albumin loss.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6727122     DOI: 10.1038/ki.1984.15

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis.

Authors:  M A Friedlander; Y C Wu; A Elgawish; V M Monnier
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

2.  Longitudinal measures of serum albumin and prealbumin concentrations in incident dialysis patients: the comprehensive dialysis study.

Authors:  Lorien S Dalrymple; Kirsten L Johansen; Glenn M Chertow; Barbara Grimes; Shuchi Anand; Charles E McCulloch; George A Kaysen
Journal:  J Ren Nutr       Date:  2012-05-26       Impact factor: 3.655

3.  A pharmacokinetic model for the glycation of albumin.

Authors:  Oskar Alskär; Julia Korell; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-04-21       Impact factor: 2.745

4.  A low-protein diet restricts albumin synthesis in nephrotic rats.

Authors:  G A Kaysen; H Jones; V Martin; F N Hutchison
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 5.  Ineffectiveness of dietary protein augmentation in the management of the nephrotic syndrome.

Authors:  H Al-Bander; G A Kaysen
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

6.  Peritoneal transport rate, systemic inflammation, and residual renal function determine peritoneal protein clearance in continuous ambulatory peritoneal dialysis patients.

Authors:  Yi Tang; Hui Zhong; Yongshu Diao; Min Qin; Xueli Zhou
Journal:  Int Urol Nephrol       Date:  2014-06-04       Impact factor: 2.370

7.  Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States.

Authors:  George A Kaysen; Kirsten L Johansen; Su-Chun Cheng; Chengshi Jin; Glenn M Chertow
Journal:  J Ren Nutr       Date:  2008-07       Impact factor: 3.655

8.  Significance of technetium-99m human serum albumin diethylenetriamine pentaacetic acid scintigraphy in patients with nephrotic syndrome.

Authors:  Tsuyoshi Takashima; Tomoya Kishi; Koji Onozawa; Shuichi Rikitake; Motoaki Miyazono; Takateru Otsuka; Hiroyuki Irie; Ryuichi Iwakiri; Kazuma Fujimoto; Yuji Ikeda
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

9.  Impact of heavy proteinuria on clinical outcomes in patients on incident peritoneal dialysis.

Authors:  Seok Hui Kang; Kyu Hyang Cho; Jong Won Park; Kyung Woo Yoon; Jun Young Do
Journal:  BMC Nephrol       Date:  2012-12-17       Impact factor: 2.388

10.  The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients.

Authors:  Taner Basturk; Abdulkadir Unsal; Yener Koc; Eren Nezaket; Elbis Ahbap; Tamer Sakaci; Mustafa Sevinc
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.